Objectives Few studies have investigated the features associated with pain levels during
abortion. We aimed to investigate the risk factors for experiencing pain during medication …

The objective of this study was to identify predictors of narcotic analgesic use during medical
abortion. Two-thousand-seven-hundred-forty-seven women with pregnancies of 63 days …

Introduction Women experience pain during medical abortion, yet optimal pain management
remains unclear. We studied the pain experience and need of analgesics during early …

Objectives: Although medical abortion with home use of misoprostol has been shown to be
safe and acceptable, there are few data about the experience of pain during the procedure …

OBJECTIVE: To determine the efficacy of a nonsteroidal anti-inflammatory drug vs.
paracetamol in pain relief during medical abortion and to evaluate whether nonsteroidal anti …

Previous studies of medical abortion with mifepristone and a prostaglandin have reported
percentages of subjects who experience cramping and/or bleeding relative to prostaglandin …

Evidence-based guidelines on the management of pain associated with first-trimester
medical abortion are lacking. Most published clinical trials have failed to report on this …

Background Abortion is common worldwide and increasingly abortions are performed at
less than 14 weeks' gestation using medical methods, specifically using a combination of …

Objective We aimed to characterize the current pain experience of patients completing an
evidence-based mifepristone-misoprostol medication abortion regimen using real-time pain …

Second trimester abortions constitute 10–15% of all induced abortions worldwide but are
responsible for two-thirds of major abortion-related complications. During the last decade …